Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ting Du, Ph.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ray A, Song Y, Du T, Buon L, Tai YT, Chauhan D, Anderson KC. Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma. Blood Cancer J. 2022 Apr 01; 12(4):50. PMID: 35365613.
    Citations:    Fields:    
  2. Liu W, Ping L, Xie Y, Sun Y, Du T, Niu Y, Cisternas G, Huang F, Garcia-Vargas J, Childs BH, Mehra A, Reschke S, Wang X, Song Y, Zhu J. A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma. Cancer Chemother Pharmacol. 2022 Mar 23. PMID: 35322287.
    Citations:    Fields:    
  3. Ray A, Song Y, Du T, Chauhan D, Anderson KC. Correction: Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma. Oncogene. 2021 Oct; 40(41):6057. PMID: 34489552.
    Citations:    Fields:    
  4. Kong XJ, Liu K, Zhuang P, Tian R, Liu S, Clairmont C, Lin X, Sherman H, Zhu J, Wang Y, Fong M, Li A, Wang BK, Wang J, Yu Z, Shen C, Cui X, Cao H, Du T, Wan G, Cao X. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial. Probiotics Antimicrob Proteins. 2021 12; 13(6):1508-1520. PMID: 34115318.
    Citations: 1     Fields:    Translation:HumansCells
  5. Ying Z, He T, Wang X, Zheng W, Lin N, Tu M, Xie Y, Ping L, Zhang C, Liu W, Deng L, Wu M, Feng F, Leng X, Du T, Qi F, Hu X, Ding Y, Lu XA, Song Y, Zhu J. Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies. BMC Cancer. 2021 Feb 25; 21(1):198. PMID: 33632155.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  6. Kong XJ, Wan G, Tian R, Liu S, Liu K, Clairmont C, Lin X, Zhang X, Sherman H, Zhu J, Wang Y, Fong M, Li A, Wang BK, Wang J, Liu J, Yu Z, Shen C, Cui X, Cao H, Du T, Cao X. The Effects of Probiotic Supplementation on Anthropometric Growth and Gut Microbiota Composition in Patients With Prader-Willi Syndrome: A Randomized Double-Blinded Placebo-Controlled Trial. Front Nutr. 2021; 8:587974. PMID: 33681271.
    Citations: 2     
  7. Ray A, Du T, Song Y, Buhrlage SJ, Chauhan D, Anderson KC. Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunity. Leukemia. 2021 08; 35(8):2435-2438. PMID: 33487632.
    Citations:    Fields:    Translation:HumansCells
  8. Song Y, Du T, Ray A, Chauhan K, Samur M, Munshi N, Chauhan D, Anderson KC. Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13. Blood Cancer J. 2021 01 13; 11(1):13. PMID: 33441535.
    Citations: 1     Fields:    Translation:HumansCells
  9. Du T, Lin S, Ji M, Xue N, Liu Y, Zhang Z, Zhang K, Zhang J, Zhang Y, Wang Q, Sheng L, Li Y, Lu D, Chen X, Xu H. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity. Cancer Lett. 2020 12 28; 495:22-32. PMID: 32931884.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  10. Du T, Song Y, Ray A, Chauhan D, Anderson KC. Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13. Leukemia. 2021 02; 35(2):550-561. PMID: 32424294.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  11. Liu W, Ji X, Song Y, Wang X, Zheng W, Lin N, Tu M, Xie Y, Ping L, Ying Z, Zhang C, Deng L, Wu M, Feng F, Leng X, Sun Y, Du T, Zhu J. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades. Cancer Med. 2020 06; 9(11):3765-3774. PMID: 32281275.
    Citations: 12     Fields:    Translation:Humans
  12. Ray A, Song Y, Du T, Chauhan D, Anderson KC. Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma. Oncogene. 2020 03; 39(13):2786-2796. PMID: 32024967.
    Citations: 13     Fields:    Translation:HumansCells
  13. Ray A, Song Y, Du T, Tai YT, Chauhan D, Anderson KC. Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma. Leukemia. 2020 02; 34(2):567-577. PMID: 31462737.
    Citations: 4     Fields:    Translation:HumansCells
  14. Du T, Fernandez C, Barshop R, Fonseca V, Chen W, Bazzano LA. Variabilities in Childhood Cardiovascular Risk Factors and Incident Diabetes in Adulthood: The Bogalusa Heart Study. Diabetes Care. 2019 09; 42(9):1816-1823. PMID: 31320447.
    Citations: 1     Fields:    Translation:Humans
  15. Song Y, Park PMC, Wu L, Ray A, Picaud S, Li D, Wimalasena VK, Du T, Filippakopoulos P, Anderson KC, Qi J, Chauhan D. Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma. Leukemia. 2019 11; 33(11):2685-2694. PMID: 30962579.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  16. Lv Y, Du T, Ji M, Wang C, Lin S, Xue N, Jin J, Xu H, Chen X. A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC. J Drug Target. 2019 04; 27(4):451-459. PMID: 30381967.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  17. Du TT, Cui T, Qiu HM, Wang NR, Huang D, Jiang XH. Simultaneous determination of tryptophan, kynurenine, kynurenic acid and two monoamines in rat plasma by HPLC-ECD/DAD. J Pharm Biomed Anal. 2018 Sep 05; 158:8-14. PMID: 29843007.
    Citations: 2     Fields:    Translation:Animals
  18. Liu W, Wang X, Zhang C, Xie Y, Lin N, Tu M, Ping L, Ying Z, Deng L, Huang H, Wu M, Sun Y, Du T, Leng X, Ding N, Zheng W, Song Y, Zhu J. [Comparison of prognostic models for patients with early-stage diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2016 Apr; 37(4):269-72. PMID: 27093984.
    Citations:    Fields:    Translation:Humans
  19. Wang Z, Du T, Dong X, Li Z, Wu G, Zhang R. Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress. Int J Oncol. 2016 Jun; 48(6):2558-66. PMID: 27035631.
    Citations: 23     Fields:    Translation:HumansCells
  20. Du T, Sun X, Lu H, Lin X, Liu Q, Huo R, Yu X. Associations of serum uric acid levels with cardiovascular health factors: differences by sex, age and body mass index in Chinese participants. Eur J Intern Med. 2014 Apr; 25(4):388-93. PMID: 24702838.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Du's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (139)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.